eMedevents
  • 130523+ Medical Conferences
  • 251 Specialties
  • 34274 Organizers
  • 147490 Speakers
  • 155 Countries
  • 4440 Cities
43508+
CME Conference Registrations Sold
Home  >  Speakers  >  Michael A. Postow
Michael A. Postow

Michael A. Postow

    MD
New York, New York    United States of America
Oncology
Oncology, Internal Medicine,...More
Spoken at 10 events
Speaking at 1 event

Biography :

Michael Postow, MD is a medical oncologist on faculty in the Melanoma and Immunotherapeutics Oncology Service at Memorial Sloan Kettering Cancer Center. He was the principal investigator of a clinical trial which led to FDA approval of the nivolumab + ipilimumab immunotherapy combination to treat melanoma and is currently leading other studies testing immunotherapy combinations for patients with advanced melanoma and other cancers. He has published first or senior author publications related to immunotherapy and melanoma care in the New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology. He enjoys traveling to speak about topics related to research and treatment of advanced melanoma.

*****************
************* ************
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Oncology

Interested Topics

Oncology, Internal Medicine, Clinical Trials, Immunotherapeutic Strategies, Research and Development, Clinical Research, Radiotherapy, Pharmacodynamic, Radiation Oncology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

Close

Send Message